Charles Fitzgerald bought $501k of XRN
director at Global Medical REIT Inc.. 14,000 shares at an average of $35.78, traded Aug 11, 2026, filed Aug 13, 2026.
Score components
- +15RoleDirector
- +18Trade size$501k at market
- +3Relative to holdingsHoldings up 11%
- 0Price contextNear the top of the 52-week range
- +15Cluster4 insiders buying within 14 days
- +5Repeat buying2 buys in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-26-095423, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 11, 2026 | POpen-market purchase Common Stockindirect: Maewyn Value Partners LP | +14,000 | $35.78 | $501k | 138,893 | Aug 13, 2026 |
Related signals
Other insiders at Global Medical REIT Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 46Moderate | Global Medical REIT Inc. | Matthew Fitzsimmons Whitlock Chief Investment Officer | $37k 1,000 shares | +100% | |
| 45Moderate | Global Medical REIT Inc. | Mark Okey Decker Jr CEO and President | $20k 550 shares | +1% | |
| 61Notable | Global Medical REIT Inc. | Aaron Robert Roseth COO | $496k 13,500 shares | - | |
| 66Notable | Global Medical REIT Inc. | Mark Okey Decker Jr CEO and President | $247k 6,875 shares | +10% | |
| 61Notable | Global Medical REIT Inc. | Charles Fitzgerald director | $992k 27,600 shares | +28% | |
| 67Notable | Global Medical REIT Inc. | Mark Okey Decker Jr CEO and President | $287k 8,000 shares | +13% | |
| 47Moderate | Global Medical REIT Inc. | Matthew Cypher director | $50k 1,420 shares | +526% | |
| 45Moderate | Global Medical REIT Inc. | Jamie Allen Barber General Counsel and Secretary | $50k 1,481 shares | - | |
| 47Moderate | Global Medical REIT Inc. | Ronald Marston director | $51k 1,500 shares | +96% | |
| 48Moderate | Global Medical REIT Inc. | Lori Wittman director | $100k 2,940 shares | - |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.